Ausgewählte Publikationen / Selected Publications

Baschant U, Lane NE, Tuckermann J. (2012). The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat Rev Rheumatol. 2012 Oct 9. doi: 10.1038/nrrheum.2012.166. [Epub ahead of print]

Illing A, Liu P, Ostermay S, Schilling A, de Haan G, Krust A, Amling M, Chambon P, Schinke T, Tuckermann JP. Estradiol increases hematopoietic stem and progenitor cells independent on its actions on bone. Haematologica. 2012 Feb 27. [Epub ahead of print]

Baschant U, Frappart L, Rauchhaus U, Bruns L, Kamradt T, Bräuer R, Tuckermann JP (2011). Glucocorticoid therapy of arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc Natl Acad Sci in press IF: 9.8
Evaluated by "Faculty of 1000" 

Kleiman A, Hübner S, Rodriguez Parkitna JM, Hofer S, Weigand M, Bauer M, Schmid W, Schütz G, Libert C, Reichardt HM, Tuckermann JP. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of Interleukin -1 in macrophages. FASEB J Oct 31. [Epub ahead of print] IF: 6.4

Rauch A*, Gossye V*, Bracke D, Gevaert E, Jacques P, van Bendeden K, Vandooren B, Rauner M, Hofbauer LC, Haegeman G, Elewaut D, Tuckermann JP**, De Bosscher K** (2011). An anti-inflammatory selective glucocorticoid receptor modulator protects osteoblast differentiation. FASEB J 25, 1323-32. IF: 6.4  

Rauch A, Seitz S, Baschant, U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss M, Angel PE, Lerner UH, David JP, Reichard HM, Amling M, Schütz G, JP Tuckermann (2010). Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell metabolism 11, 517-531. IF: 17.4